The FDA has given SonoSite the go-ahead to begin marketing its new NanoMaxx ultrasound system. The company said U.S. customer deliveries will begin shipping immediately.
SonoSite’s NanoMaxx Enters U.S.
The FDA has given SonoSite the go-ahead to begin marketing its new NanoMaxx ultrasound system. The company said U.S. customer deliveries will begin shipping immediately. International deliveries began in June. Featuring one-button optimization technology, the six pound NanoMaxx system will be marketed as a point-of-care system to hospitals and physician offices. The system, which boots up in less than 20 seconds, comes with five transducers to support thoracic assessment for pathology, vascular access, and needle aspirations and injections, as well as abdominal, cardiac, nerve, OB/Gyn, musculoskeletal, small parts and vascular scanning. NanoMaxx can be wall mounted, placed on an exam table with kickstand attached, used from a floor-based stand, or hand carried.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.